Moroz Larysa V, Chichirelo-Konstantynovych Kiarina D, Konstantynovych Tetyana V, Dudnyk Veronika M
Department of Infectious Diseases, National Pirogov Memorial Medical University, Vinnytsia, Ukraine.
Department of Propedeutics of Internal Medicine, National Pirogov Memorial Medical University, Vinnytsia, Ukraine.
Lung India. 2019 Jul-Aug;36(4):319-323. doi: 10.4103/lungindia.lungindia_355_18.
The aim of this study was to determine the predictive role of TLR4 polymorphism in CAP course among young cytomegalovirus-positive patients.
One hundred and five patients with pneumonia (age range: 18-44 years) and 61 healthy respondents were observed clinically and specifically (by cytomegalovirus markers and TLR4 + 3725 G/C polymorphism).
Among CAP patients, there were 51 male (48.6%) and 54 female (51.4%), with average age 34.1 ± 0.8 years, and there were 19 (18.1%) patients with Pneumonia Patient Outcomes Research Team (PORT) I, 46 (43.8%) patients with PORT II, 31 (29.5%) patients with PORT III, and 9 (8.6%) patients with PORT IV. Cytomegalovirus persistence was detected in 80 (48.2%) patients and 34 (20.5%) healthy respondents (P = 0.003). G/G genotype of TLR4 signaling was found in 78 (74%) patients with pneumonia, G/C in 24 (23%) patients, and C/C in 3 (3%) patients. Among G/C patients, there were 16.2% cytomegalovirus-positive patients versus 6.7% negative patients (P < 0.05), as well as among G/G patients, and there were 59% versus 15,2%, accordingly (P < 0.01). The patients of the main group with G/G genotype were characterized by mostly mild (PORT I - 15 [14.3%]) and moderate pneumonia severity (PORT II - 32 [30.5%] and PORT III - 26 [24.8%] patients). The patients with G/C genotype were characterized by mostly PORT II (11 [10.5%] patients). All C/C genotype patients have PORT II (P < 0.05).
Cytomegalovirus persistence worsens the pneumonia course. G/G and G/C TLR4 genotypes are associated with mild pneumonia severity.
本研究旨在确定TLR4基因多态性在年轻巨细胞病毒阳性患者社区获得性肺炎(CAP)病程中的预测作用。
对105例肺炎患者(年龄范围:18 - 44岁)和61名健康对照者进行临床观察及特异性检测(通过巨细胞病毒标志物和TLR4 + 3725 G/C基因多态性)。
在CAP患者中,男性51例(48.6%),女性54例(51.4%),平均年龄34.1±0.8岁。肺炎患者预后研究团队(PORT)I级患者19例(18.1%),PORT II级患者46例(43.8%),PORT III级患者31例(29.5%),PORT IV级患者9例(8.6%)。80例(48.2%)患者和34名(20.5%)健康对照者检测到巨细胞病毒持续感染(P = 0.003)。肺炎患者中,TLR4信号通路的G/G基因型78例(74%),G/C基因型24例(23%),C/C基因型3例(3%)。在G/C基因型患者中,巨细胞病毒阳性患者占16.2%,阴性患者占6.7%(P < 0.05);在G/G基因型患者中相应比例分别为59%和15.2%(P < 0.01)。主要组中G/G基因型患者大多表现为轻度(PORT I - 15例[14.3%])和中度肺炎严重程度(PORT II - 32例[30.5%]和PORT III - 26例[24.8%])。G/C基因型患者大多为PORT II级(11例[10.5%])。所有C/C基因型患者均为PORT II级(P < 0.05)。
巨细胞病毒持续感染会使肺炎病程恶化。G/G和G/C TLR4基因型与轻度肺炎严重程度相关。